JP2001513506A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001513506A5 JP2001513506A5 JP2000506977A JP2000506977A JP2001513506A5 JP 2001513506 A5 JP2001513506 A5 JP 2001513506A5 JP 2000506977 A JP2000506977 A JP 2000506977A JP 2000506977 A JP2000506977 A JP 2000506977A JP 2001513506 A5 JP2001513506 A5 JP 2001513506A5
- Authority
- JP
- Japan
- Prior art keywords
- chromium
- biotin
- amount
- pharmaceutical composition
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 36
- 229960002685 biotin Drugs 0.000 claims 18
- 235000020958 biotin Nutrition 0.000 claims 18
- 239000011616 biotin Substances 0.000 claims 18
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims 12
- 229910052804 chromium Inorganic materials 0.000 claims 12
- 239000011651 chromium Substances 0.000 claims 12
- -1 chromium tripicolinate Chemical compound 0.000 claims 10
- 230000002195 synergetic effect Effects 0.000 claims 8
- 239000003937 drug carrier Substances 0.000 claims 4
- 238000007911 parenteral administration Methods 0.000 claims 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- 230000000996 additive effect Effects 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- 201000001421 hyperglycemia Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 230000000087 stabilizing effect Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/908,819 US5789401A (en) | 1997-08-08 | 1997-08-08 | High-dose chromium/biotin treatment of type II diabetes |
| US08/908,819 | 1997-08-08 | ||
| US09/110,511 | 1998-07-06 | ||
| US09/110,511 US5929066A (en) | 1997-08-08 | 1998-07-06 | Chromium/biotin treatment of Type II diabetes |
| PCT/US1998/016103 WO1999007387A1 (en) | 1997-08-08 | 1998-07-31 | Chromium/biotin treatment of type ii diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001513506A JP2001513506A (ja) | 2001-09-04 |
| JP2001513506A5 true JP2001513506A5 (https=) | 2005-08-04 |
Family
ID=26808096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000506977A Pending JP2001513506A (ja) | 1997-08-08 | 1998-07-31 | タイプｉｉ糖尿病のクロム／ビオチン治療 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | USRE39480E1 (https=) |
| EP (1) | EP1001793B1 (https=) |
| JP (1) | JP2001513506A (https=) |
| CN (1) | CN1273531A (https=) |
| AT (1) | ATE304364T1 (https=) |
| AU (1) | AU751431B2 (https=) |
| BR (1) | BR9811137A (https=) |
| CA (1) | CA2297834C (https=) |
| CZ (1) | CZ298680B6 (https=) |
| DE (1) | DE69831576T2 (https=) |
| ES (1) | ES2251097T3 (https=) |
| HU (1) | HUP0003713A2 (https=) |
| IL (1) | IL134163A0 (https=) |
| WO (1) | WO1999007387A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5962030A (en) | 1997-03-07 | 1999-10-05 | Akesis Pharmaceuticals, Inc. | Dietary supplement and method of treatment for diabetic control |
| AU751431B2 (en) | 1997-08-08 | 2002-08-15 | Nutrition 21 | Chromium/biotin treatment of type II diabetes |
| CA2344246A1 (en) | 1998-09-17 | 2000-03-23 | Akesis Pharmaceuticals, Inc. | Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders |
| US6376549B1 (en) | 1998-09-17 | 2002-04-23 | Akesis Pharmaceuticals, Inc. | Metforimin-containing compositions for the treatment of diabetes |
| PT1397148E (pt) * | 2001-02-27 | 2006-11-30 | Nutrition 21 Inc | Tratamento da dislipidemia com crómio/biotina |
| US20050214384A1 (en) * | 2002-04-23 | 2005-09-29 | Vijaya Juturu | Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance |
| JP2004043443A (ja) * | 2002-05-14 | 2004-02-12 | Kumamoto Technology & Industry Foundation | アミロイドーシスの予防及び治療のための医薬 |
| ATE476188T1 (de) * | 2002-05-14 | 2010-08-15 | Nipro Corp | Medikament zur prävention und behandlung von familiärer amyloid polyneuropathie |
| JP2004203863A (ja) * | 2002-12-09 | 2004-07-22 | Taisho Pharmaceut Co Ltd | 抗糖尿病用組成物 |
| CN1320925C (zh) * | 2005-03-30 | 2007-06-13 | 淮北市辉克药业有限公司 | 长期使用的治疗糖尿病的复方制剂 |
| CA3021932C (en) * | 2007-01-31 | 2020-12-15 | Jds Therapeutics, Llc | Use of chromium histidinate for treatment of cardiometabolic disorders |
| ES2841379T3 (es) | 2007-03-13 | 2021-07-08 | Jds Therapeutics Llc | Procedimientos y composiciones para la liberación sostenida de cromo |
| WO2009002867A2 (en) | 2007-06-26 | 2008-12-31 | Nutrition 21, Inc. | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement |
| AU2012223282B2 (en) | 2011-03-01 | 2017-02-02 | Nutrition 21, Llc | Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders |
| ES2395529B1 (es) | 2011-06-08 | 2014-04-11 | Pri, S.A. | Combinación sinérgica para el tratamiento de la diabetes mellitus tipo 2. |
| CN102488220A (zh) * | 2011-11-28 | 2012-06-13 | 中哈福生物医药科技（上海）有限公司 | 降血糖组合物，其制备方法及具有降血糖功能的保健食品 |
| CA3014308A1 (en) | 2016-02-11 | 2017-08-17 | Nutrition 21, Llc | Chromium containing compositions for improving health and fitness |
| US10820617B1 (en) | 2018-03-29 | 2020-11-03 | Government Of The United States, As Represented By The Secretary Of The Air Force | All inclusive electrolytes, vitamins, and protein powder training supplement |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4315927A (en) * | 1980-08-08 | 1982-02-16 | The United States Of America As Represented By The Secretary Of Agriculture | Dietary supplementation with essential metal picolinates |
| US5087623A (en) * | 1988-05-31 | 1992-02-11 | Nitrition 21 | Chromic picolinate treatment |
| US6140304A (en) | 1988-09-28 | 2000-10-31 | Eicotech Corporation | Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia |
| BR9105986A (pt) * | 1990-02-05 | 1992-11-10 | Univ Texas | Formulacao de liberacao por tempo de vitaminas,minerais e outros suplementos beneficos |
| US5336672A (en) * | 1992-07-21 | 1994-08-09 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Increasing egg production in poultry |
| US5470846A (en) * | 1994-01-14 | 1995-11-28 | Sandyk; Reuven | Treatment of neurological and mental disorders |
| US5496827A (en) * | 1994-07-15 | 1996-03-05 | Patrick; Jay | Compositions for the transdermal delivery of nutrients |
| US5744161A (en) * | 1995-02-24 | 1998-04-28 | Sabinsa Corporation | Use of piperine as a bioavailability enhancer |
| US6329361B1 (en) * | 1995-05-12 | 2001-12-11 | Nutrition 21 | High-dose chromic picolinate treatment of type II diabetes |
| US5597585A (en) * | 1995-12-26 | 1997-01-28 | Williams; Andrew H. | Vitamin/mineral composition |
| US5635535A (en) * | 1996-04-05 | 1997-06-03 | Wagstaff; Robert K. | Method for increasing blood glucose levels |
| US5789401A (en) * | 1997-08-08 | 1998-08-04 | Nutrition 21 | High-dose chromium/biotin treatment of type II diabetes |
| AU751431B2 (en) | 1997-08-08 | 2002-08-15 | Nutrition 21 | Chromium/biotin treatment of type II diabetes |
| US6048846A (en) * | 1998-02-26 | 2000-04-11 | Cochran; Timothy M. | Compositions used in human treatment |
| US6365176B1 (en) | 2000-08-08 | 2002-04-02 | Functional Foods, Inc. | Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy |
-
1998
- 1998-07-31 AU AU87651/98A patent/AU751431B2/en not_active Ceased
- 1998-07-31 HU HU0003713A patent/HUP0003713A2/hu unknown
- 1998-07-31 CA CA002297834A patent/CA2297834C/en not_active Expired - Lifetime
- 1998-07-31 EP EP98939166A patent/EP1001793B1/en not_active Expired - Lifetime
- 1998-07-31 IL IL13416398A patent/IL134163A0/xx active IP Right Grant
- 1998-07-31 WO PCT/US1998/016103 patent/WO1999007387A1/en not_active Ceased
- 1998-07-31 CZ CZ20000324A patent/CZ298680B6/cs not_active IP Right Cessation
- 1998-07-31 AT AT98939166T patent/ATE304364T1/de not_active IP Right Cessation
- 1998-07-31 CN CN98807961A patent/CN1273531A/zh active Pending
- 1998-07-31 BR BR9811137-0A patent/BR9811137A/pt not_active Application Discontinuation
- 1998-07-31 JP JP2000506977A patent/JP2001513506A/ja active Pending
- 1998-07-31 DE DE69831576T patent/DE69831576T2/de not_active Expired - Lifetime
- 1998-07-31 ES ES98939166T patent/ES2251097T3/es not_active Expired - Lifetime
-
2001
- 2001-07-24 US US09/912,472 patent/USRE39480E1/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001513506A5 (https=) | ||
| JPH11139971A5 (https=) | ||
| CA2339991A1 (en) | Microemulsions as solid dosage forms for oral administration | |
| GEP20094723B (en) | Tetraazabenzo [e] azulene derivatives and analogs thereof | |
| JP2007515469A5 (https=) | ||
| JP2005515966A5 (https=) | ||
| GB0119249D0 (en) | Organic compounds | |
| JP2001520189A5 (https=) | ||
| GEP20074208B (en) | Substituted amides active at the cannabinoid-1 receptor | |
| CA2440111A1 (en) | Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative | |
| BR0110837A (pt) | Quimioterapia de combinação | |
| MY118156A (en) | Oral compositions of levosimendan. | |
| RU2000106035A (ru) | Лечение диабета ii типа с использованием хрома/биотина | |
| JP2002519425A5 (https=) | ||
| JP2005512965A5 (https=) | ||
| NZ516290A (en) | Substituted phenoxyacetic acids | |
| CA2270955A1 (en) | Pharmaceutical composition containing morphinan derivative for treating drug dependence | |
| JP2005525329A5 (https=) | ||
| WO2000048445A3 (de) | Pharmazeutische zusammensetzung enthaltend desoxypeganin zur behandlung der nikotinabhängigkeit | |
| IL312679A (en) | Compounds for the treatment of anemia associated with MDS and other conditions | |
| WO2005013935A3 (en) | Composition for releasing a weak base for an extended period of time | |
| BE2016C017I2 (https=) | ||
| JP2004506605A5 (https=) | ||
| AU3278800A (en) | Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence | |
| CA2504665A1 (en) | Combination of a nitrogen mustard analogue and imatinib for the treatment of chronic lymphocytic leukemia |